Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $63.52M | $377.71M | -83.18% |
Operating Income | $-415.57M | $-176.49M | -135.47% |
Net Income | $-376.74M | $-132.53M | -184.28% |
EPS (Basic) | $-4.58 | $-1.72 | -166.28% |
EPS (Diluted) | $-4.58 | $-1.72 | -166.28% |
R&D Expense | $367.56M | $437.38M | -15.96% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.1B | $1.46B | -24.38% |
Current Assets | $878.15M | $1.21B | -27.49% |
Total Liabilities | $370.28M | $478.38M | -22.60% |
Current Liabilities | $182.07M | $205.56M | -11.43% |
Stockholders' Equity | $733.54M | $981.33M | -25.25% |
Cash & Equivalents | $281.97M | $435.89M | -35.31% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-347.25M | $-149.19M | -132.75% |
Investing Cash Flow | $185.01M | $71.84M | +157.53% |
Financing Cash Flow | $7.74M | $276.45M | -97.20% |
D&A | $21.93M | $20.01M | +9.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -654.3% | -46.7% | -607.53% |
Net Margin | -593.1% | — | — |
ROE | -51.4% | — | — |
ROA | -34.1% | — | — |
Current Ratio | $4.823 | — | — |
Debt to Equity | $0.505 | — | — |
Other companies in Biotechnology